Feature

ASH urges lawmakers to keep opioids accessible


 

Pain management training

While hematologists are trained about the potential risks of common drugs such as steroids, “none of that education and training has occurred” for opioids, Dr. Meier said.

Dr. Diane E. Meier, director of the Center to Advance Palliative Care in New York

Dr. Diane E. Meier

“In my view, that is a major contributor to both under- and overprescribing of opioids and has been a contributor to the crisis that our country is currently in the middle of,” she said.

Since hematologists often aren’t trained in pain management, many are uncomfortable with managing pain in their diagnosis and leave the responsibility to a pain specialist, Dr. Osunkwo said. “But the problem is, they know more about the disease than anybody else, and you’ll be safer if [they] are doing the pain management for hematology patients because they know the risk and benefit of the different drugs in light of the diagnosis itself, compared to passing that on to somebody else to manage.”

In the recent policy statement, ASH leaders committed to creating evidence-based guidelines and education activities on pain management.

Pages

Recommended Reading

Drugmakers blamed for blocking generics have cost U.S. billions
MDedge Hematology and Oncology
Congress passes ‘right to try’ legislation
MDedge Hematology and Oncology
CMS proposes inpatient payment model for CAR T therapies
MDedge Hematology and Oncology
MDedge Daily News: Keeping patients summer safe
MDedge Hematology and Oncology
Peer mentorship, groups help combat burnout in female physicians
MDedge Hematology and Oncology
Geriatric assessments enhance patient care in advanced cancer
MDedge Hematology and Oncology
Metastatic colorectal cancer chemo costs double in Washington vs. British Columbia
MDedge Hematology and Oncology
Looking for lower Medicare drug costs? Ask your pharmacist for the cash price
MDedge Hematology and Oncology
AMA: Opioid prescriptions down since 2013
MDedge Hematology and Oncology
Verma unveils Medicaid scorecard but refuses to judge efforts
MDedge Hematology and Oncology